RNAZ Institutional Ownership & Shareholders
TRANSCODE THERAPEUTICS INC (RNAZ) is currently held by 9 institutional investors tracked by InsiderSet, with a combined reported market value of approximately $208,017 based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026.
Yorkville Advisors Global, Lp is currently the largest disclosed institutional shareholder of RNAZ tracked by InsiderSet, reporting ownership valued at approximately $121,958 in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $34,761.03, representing an estimated loss of -71.50% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 100% of the total disclosed RNAZ value among the investors covered in this analysis. Major shareholders include Yorkville Advisors Global, Lp, Vanguard Capital Management Llc, Vanguard Fiduciary Trust Co, and several other long-term asset managers with concentrated positions in TRANSCODE THERAPEUTICS INC (RNAZ).
This page ranks the largest institutional RNAZ shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
9
Total Reported Value
$208,017
Largest Holder
Yorkville Advisors Global, Lp
Largest Position
$121,958
Insider Transactions (90d)
0
Latest Filing Quarter
Q2 2026
New Institutional Positions
14
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Yorkville Advisors Global, Lp | 0.14% | 19,639 | $121,958 | $34,761 | -$87,197 | -71.50% | |
| Vanguard Capital Management Llc | 0.00% | 6,545 | $40,644 | $11,585 | -$29,059 | -71.50% | |
| Vanguard Fiduciary Trust Co | 0.00% | 2,982 | $18,518 | $5,278 | -$13,240 | -71.50% | |
| Ubs Group Ag | 0.00% | 2,888 | $17,934 | $5,112 | -$12,822 | -71.50% | |
| Fmr Llc | 0.00% | 706 | $4,384 | $1,250 | -$3,134 | -71.50% | |
| Tower Research Capital Llc (Trc) | 0.00% | 677 | $4,204 | $1,198 | -$3,006 | -71.50% | |
| Wells Fargo & Company/Mn | 0.00% | 55 | $342 | $97 | -$245 | -71.54% | |
| Sbi Securities Co., Ltd. | 0.00% | 12 | $20 | $21 | +$1 | +6.20% | |
| Ifp Advisors, Inc | 0.00% | 8 | $13 | $14 | +$1 | +8.92% |
Frequently asked questions about RNAZ
Who are the largest institutional holders of RNAZ?
The largest institutional holders of RNAZ reported in the latest SEC Form 13F filings include Yorkville Advisors Global, Lp, Vanguard Capital Management Llc, Vanguard Fiduciary Trust Co, Ubs Group Ag, and Fmr Llc. InsiderSet ranks institutional holders by their latest reported RNAZ position.
What is RNAZ institutional ownership?
This page tracks RNAZ positions reported by institutional investment managers through SEC Form 13F. TRANSCODE THERAPEUTICS INC (RNAZ) institutional ownership on InsiderSet reflects disclosed 13F holdings among the managers we analyze, not every shareholder of the stock.
How many institutions own RNAZ?
InsiderSet currently tracks 9 institutional managers reporting RNAZ holdings in the latest available 13F data. This count reflects institutions included in the SEC Form 13F filings analyzed by InsiderSet and should not be interpreted as the total number of RNAZ shareholders.
How much RNAZ stock do institutions own?
Institutional investment managers disclosed approximately $208,017 in RNAZ holdings for Q2 2026. This figure is reported 13F value as of the filing period, not necessarily today's market value.
When was RNAZ institutional ownership last updated?
The latest RNAZ institutional ownership data on InsiderSet is based on SEC Form 13F filings for the quarter ended June 30, 2026. Form 13F filings are generally reported after the quarter ends, so the holdings shown represent the latest publicly disclosed positions rather than real-time institutional holdings.
Are institutional RNAZ holdings real-time?
No. Form 13F data is not real-time. It represents positions reported by institutional investment managers as of the end of the reporting quarter. An institution may have changed its RNAZ position after the reporting date.
Are institutions buying or selling RNAZ?
Institutional buying and selling can be analyzed by comparing RNAZ positions across consecutive 13F reporting periods. InsiderSet's RNAZ Ownership Changes page shows institutions that increased, reduced, initiated, or exited positions based on reported 13F holdings. View RNAZ ownership changes.
How has RNAZ institutional ownership changed over time?
InsiderSet tracks RNAZ institutional holdings across multiple 13F reporting periods, allowing investors to compare institutional holder counts, reported value, and reported shares over time.